Nia Therapeutics, Inc. is focused on developing neurostimulation therapies aimed at treating memory impairment, particularly in patients with traumatic brain injuries. Established in 2016 and based in Philadelphia, Pennsylvania, the company emerged from the University of Pennsylvania, leveraging technology developed as part of the United States BRAIN Initiative. Nia Therapeutics specializes in a device that interprets complex brain activity linked to memory function, delivering personalized therapy through deep-brain stimulation. This innovative approach seeks to enhance memory by restoring brain activity associated with improved cognitive function.
Cortera Neurotechnologies, Inc. specializes in the development of implantable medical devices designed to enhance the diagnosis and treatment of incurable neurological conditions. With a focus on wireless brain-machine interfaces, the company aims to improve patient care and quality of life while advancing neuroscientific research. Drawing on over five years of expertise in NeuroEngineering, Cortera is positioned to contribute significantly to the expanding neurodevices market, which is valued at $4.5 billion. Its innovative products integrate circuit technology for effective brain sensing and stimulation, facilitating better outcomes for both patients and medical professionals.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.